CHUL
2705, boulevard Laurier
R-0-709
Québec, Québec
Canada G1V 4G2

Dernières nouvelles

Information non disponible

35 enregistrements « 1 de 4 »

Baz M, Boivin G

Antiviral Agents in Development for Zika Virus Infections.

Article de revue

Pharmaceuticals (Basel), 12 (3), 2019, ISSN: 1424-8247.

Résumé | Liens:

Baz M, Carbonneau J, Rheaume C, Cavanagh MH, Boivin G

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.

Article de revue

Viruses, 10 (11), 2018, ISSN: 1999-4915.

Résumé | Liens:

Piret J, Carbonneau J, Rheaume C, Baz M, Boivin G

Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.

Article de revue

J Gen Virol, 99 (2), p. 209-218, 2018, ISSN: 0022-1317.

Résumé | Liens:

Tu V, Abed Y, Fage C, Baz M, Boivin G

Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.

Article de revue

Antiviral Res, 154 , p. 110-115, 2018, ISSN: 0166-3542.

Résumé | Liens:

Bolduc M, Baz M, Laliberte-Gagne ME, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Article de revue

Nanomedicine, 14 (8), p. 2563-2574, 2018, ISSN: 1549-9634.

Résumé | Liens:

Boonnak K, Matsuoka Y, Wang W, Suguitan AL Jr, Chen Z, Paskel M, Baz M, Moore I, Jin H, Subbarao K

Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.

Article de revue

J Virol, 91 (15), 2017, ISSN: 0022-538X.

Résumé | Liens:

Retamal M, Abed Y, Rheaume C, Baz M, Boivin G

In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site.

Article de revue

J Gen Virol, 98 (6), p. 1224-1231, 2017, ISSN: 0022-1317.

Résumé | Liens:

Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G

In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.

Article de revue

Antivir Ther, 22 (7), p. 613-618, 2017, ISSN: 1359-6535.

Résumé | Liens:

Stephen P, Baz M, Boivin G, Lin SX

Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors.

Article de revue

J Am Chem Soc, 138 (50), p. 16212-16215, 2016, ISSN: 0002-7863.

Résumé | Liens:

Baz M, Boonnak K, Paskel M, Santos C, Powell T, Townsend A, Subbarao K

Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge.

Article de revue

MBio, 6 (5), p. e01487-15, 2015.

Résumé | Liens:

35 enregistrements « 1 de 4 »
Signaler des ajouts ou des modifications

Projets actifs

  • Centres hospitaliers universitaires de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, du 2017-01-01 au 2099-12-31
Information provenant du registre des projets de recherche de l'Université Laval